Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study
Top Cited Papers
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (2), 211-216
- https://doi.org/10.1046/j.1523-1747.2003.12040.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort studyJournal of the American Academy of Dermatology, 2001
- Psoriasis, its Treatment, and Cancer in a Cohort of Finnish PatientsJournal of Investigative Dermatology, 2000
- PUVA and cancer risk: the Swedish follow-up studyBritish Journal of Dermatology, 1999
- A systematic review of five systemic treatments for severe psoriasisBritish Journal of Dermatology, 1997
- Malignant Melanoma in Patients Treated for Psoriasis with Methoxsalen (Psoralen) and Ultraviolet A Radiation (PUVA)New England Journal of Medicine, 1997
- Treatment of psoriasis with intermittent short course cyclosporin (Neoral®). A multicentre studyBritish Journal of Dermatology, 1997
- The effect of severe psoriasis on the quality of life of 369 patientsBritish Journal of Dermatology, 1995
- PUVA and cancer: a large-scale epidemiological studyThe Lancet, 1991
- The risk of neoplasms in patients treated with cyclosporine AJournal of Autoimmunity, 1989
- Cutaneous Squamous-Cell Carcinoma in Patients Treated with PUVANew England Journal of Medicine, 1984